Bioinformatics-Driven Molecular Docking and Molecular Dynamics Simulation of Gold Nanoparticle Ligand Complexes for Targeted Antimicrobial Applications

Authors

  • Farwa Butt College of Animal Science and Technology, Yangzhou University, Yangzhou 225009, China Author
  • Afriaz Khan Department of Zoological Sciences, University of Science and Technology, Bannu, Pakistan Author
  • Bahaaeldin Anwer Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Egypt Author
  • Saliha Khalid Department of Molecular Biology and Genetics, School of Engineering and Natural Sciences, Kadir Has University 34083, Cibali Campus Fatih, Istanbul Turkey Author

DOI:

https://doi.org/10.71000/2edmny64

Keywords:

Gold Nanoparticles, Molecular Docking, Molecular Dynamics, Antimicrobial Resistance; Bioinformatics; Nanoinformatics, Targeted Therapy

Abstract

Inorganic nanoparticles (NPs), such as gold nanoparticles (AuNPs), are one such candidate nanoplatform that has been investigated extensively for its potential to combat multidrug-resistant (MDR) pathogens, due to their tunable size, shape-dependent surface chemistry, and their ability to multivalently conjugate with ligands. Simultaneously, the development of structural bioinformatics, such as molecular docking, molecular dynamics (MD) simulation, quantitative structure activity relationship (QSAR) modelling and machine-learning (ML) toxicity prediction, has revolutionised the rationalization of interactions of nanoparticles with biomolecules before the experiments in wet laboratories. The present review critically synthesises the literature available from 2021 to 2026 dealing with the docking and MD based characterisation of the AuNP–ligand system for targeted antimicrobial therapy. The physicochemical basis of AuNP bioactivity is examined, as well as the computational tool chain developed to model AuNP protein and AuNP membrane interactions, and the translational evidence showing the correlation between in silico predictions of protein binding and in vivo antibacterial, antifungal and antibiofilm activity. Special attention is given to the diversity in the use of different methods and different force fields in docking studies, to the lack of an AuNP-specific force field to guide MD, and thus the uncertainty of transferring docking methods derived from small molecules to a polydisperse AuNP system of many valence states. Based on this, we believe the field has yielded promising binding-affinity and mechanistic information, but there is still a significant disconnect between computational prediction and reproducible clinical translation, and we highlight the areas that need to be addressed to bridge this gap, such as standardisation of the representation of the nanoparticles, treatment of the gold core by hybrid quantum mechanics/molecular mechanics (QM/MM), and integrated ML-driven toxicity screening.

References

World Health Organization. Antimicrobial resistance [Internet]. Geneva: World Health Organization; 2026 [cited 2026 Aug 7]. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-655. doi:10.1016/S0140-6736(21)02724-0.

GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199-1226. doi:10.1016/S0140-6736(24)01867-1.

Ntais C, Chatziprodromidou IP. Antimicrobial resistance as a global public health challenge: epidemiological burden, bioethical dimensions and emerging therapeutic strategies. Infect Dis Rep. 2026;18(4):70. doi:10.3390/idr18040070.

Chaturvedi A, Ranjan R. Antimicrobial nanoparticles: a new horizon to combat multidrug-resistant bacteria. Front Nanotechnol. 2025;7:1611126. doi:10.3389/fnano.2025.1611126.

Elbehiry A, Abalkhail A. Antimicrobial nanoparticles against superbugs: mechanistic insights, biomedical applications, and translational frontiers. Pharmaceuticals (Basel). 2025;18(8):1195. doi:10.3390/ph18081195.

Sharma D, Gautam S, Singh S, Srivastava N, Khan AM, Bisht D. Unveiling the nanoworld of antimicrobial resistance: integrating nature and nanotechnology. Front Microbiol. 2025;15:1391345. doi:10.3389/fmicb.2024.1391345.

Huq MA, Rana MR, Samad A, Rahman MS, Rahman MM, Ashrafudoulla M, et al. Green synthesis, characterization, and potential antibacterial and anticancer applications of gold nanoparticles: current status and future prospects. Biomedicines. 2025;13(5):1184. doi:10.3390/biomedicines13051184.

Georgeous J, AlSawaftah N, Abuwatfa WH, Husseini GA. Review of gold nanoparticles: synthesis, properties, shapes, cellular uptake, targeting, release mechanisms and applications in drug delivery and therapy. Pharmaceutics. 2024;16(10):1332. doi:10.3390/pharmaceutics16101332.

Sharma D, Shandilya P, Saini NK, Singh P, Thakur VK, Saini RV, et al. Insights into the synthesis and mechanism of green synthesized antimicrobial nanoparticles, answer to the multidrug resistance. Mater Today Chem. 2021;19:100391. doi:10.1016/j.mtchem.2020.100391.

Khalifa HO, Alkhoori H. Beyond the glitter: gold nanoparticles as powerful weapons against multi-drug resistant pathogens. Front Mol Biosci. 2025;12:1612526. doi:10.3389/fmolb.2025.1612526.

Gong Y, Wu D, Yan X, Zhang Q, Zheng W, Li B, et al. Unveiling the antibacterial mechanism of gold nanoparticles by analyzing bacterial metabolism at the molecular level. Anal Chem. 2024;96(47):18865-18872. doi:10.1021/acs.analchem.4c04571.

Janani M, Anooj ES. Unveiling the antibacterial efficacy of gold nanoparticles: a critical review. Arch Microbiol. 2026;208(5):237. doi:10.1007/s00203-026-04783-z.

Khalifa HO, Oreiby A, Mohammed T, Abdelhamid MAA, Sholkamy EN, Hashem H, et al. Silver nanoparticles as next-generation antimicrobial agents: mechanisms, challenges, and innovations against multidrug-resistant bacteria. Front Cell Infect Microbiol. 2025;15:1599113. doi:10.3389/fcimb.2025.1599113.

Bugnon M, Röhrig UF, Goullieux M, Perez MAS, Daina A, Michielin O, Zoete V. SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina. Nucleic Acids Res. 2024;52(W1):W324-W332. doi:10.1093/nar/gkae300.

Che X, Liu Q, Zhang L. An accurate and universal protein-small molecule batch docking solution using AutoDock Vina. Results Eng. 2023;19:101335. doi:10.1016/j.rineng.2023.101335.

Sarkar A, Concilio S, Sessa L, Marrafino F, Piotto S. Advancements and novel approaches in modified AutoDock Vina algorithms for enhanced molecular docking. Results Chem. 2024;7:101319. doi:10.1016/j.rechem.2024.101319.

Kar P, Oriola AO, Oyedeji AO. Molecular docking approach for biological interaction of green synthesized nanoparticles. Molecules. 2024;29(11):2428. doi:10.3390/molecules29112428.

Mishra P, Faruqui T, Khanam S, Khubaib M, Ahmad I, Saeed M, Khan S. Sustainable synthesis of bakuchiol-mediated gold nanoparticles for drug delivery against bacterial strains and tumor microenvironments, and its in silico target proteins identification. Front Mol Biosci. 2024;11:1469107. doi:10.3389/fmolb.2024.1469107.

Zatla I, Boublenza L. Battling COVID-19 leveraging nanobiotechnology: gold and silver nanoparticle-B-escin conjugates as SARS-CoV-2 inhibitors. Open Life Sci. 2025;20(1):20221047. doi:10.1515/biol-2022-1047.

Khan SA, Almuqrin A, Seneviratne CJ, Pant KK, Ziora ZM, Blaskovich MAT. Antibiofilm efficacy of a green graphene oxide-silver nanocomposite against mixed microbial species biofilms: an in vitro and in silico approach. RSC Sustain. 2025;3(11):5249-5259. doi:10.1039/D5SU00093A.

Lahiri D, Ray RR, Sarkar T, Upadhye VJ, Ghosh S, Pandit S, et al. Anti-biofilm efficacy of green-synthesized ZnO nanoparticles on oral biofilm: in vitro and in silico study. Front Microbiol. 2022;13:939390. doi:10.3389/fmicb.2022.939390.

Liu H, Pei Y. Atomistic molecular dynamics simulation study on the interaction between atomically precise thiolate-protected gold nanoclusters and phospholipid membranes. Langmuir. 2022;38(5):1653-1661. doi:10.1021/acs.langmuir.1c02001.

Tavanti F, Pedone A, Menziani MC. Disclosing the interaction of gold nanoparticles with Aβ(1-40) monomers through replica exchange molecular dynamics simulations. Int J Mol Sci. 2021;22(1):26. doi:10.3390/ijms22010026.

Coelho E, de Andrade DX, de Almeida AR, Colherinhas G. Molecular dynamics study of functionalized gold nanoparticles: structural and aggregation behavior under varying ionic strength. ACS Phys Chem Au. 2025;5(6):699-715. doi:10.1021/acsphyschemau.5c00077.

Farhadian N, Samadi Kazemi M, Moosavi Baigi F, Khalaj M. Molecular dynamics simulation of drug delivery across the cell membrane by applying gold nanoparticle carrier: flutamide as hydrophobic and glutathione as hydrophilic drugs as the case studies. J Mol Graph Model. 2022;116:108271. doi:10.1016/j.jmgm.2022.108271.

Rajchakit U, Lamba S, Wang K, Lyons N, Lu J, Swift S, et al. Size-controlled synthesis of gold nanoparticles tethering antimicrobial peptides with potent broad-spectrum antimicrobial and antibiofilm activities. Mol Pharm. 2024;21(2):596-608. doi:10.1021/acs.molpharmaceut.3c00734.

Choudhury S, Mehra A, Srivastava S, Sharma M, Singh M, Panda JJ. Lipopolysaccharide targeting-peptide-capped chitosan gold nanoparticles for laser-induced antibacterial activity. Nanomedicine (Lond). 2024;19(23):1913-1929. doi:10.1080/17435889.2024.2382073.

Athauda ID, Shetty MG, Pai P, Hegde M, Gurumurthy SC, Babitha KS. Enhanced bactericidal effects and drug delivery with gentamicin-conjugated nanoparticles. J Clust Sci. 2024;35(2):371-390. doi:10.1007/s10876-023-02501-z.

Alalmaie A, Alshahrani HT, Alqahtani M, Alshahrani Z, Alahmari S, Asiri A, et al. Integrating computational insights in gold nanoparticle-mediated drug delivery: enhancing efficacy and precision. Front Med Technol. 2025;7:1528826. doi:10.3389/fmedt.2025.1528826.

Agüero-Chapin G, Antunes A, Marrero-Ponce Y. A 2022 update on computational approaches to the discovery and design of antimicrobial peptides. Antibiotics (Basel). 2023;12(6):1011. doi:10.3390/antibiotics12061011.

Do Carmo PHF, Lage ACP, Garcia MT, da Silva NS, Santos DA, Mylonakis E, et al. Resveratrol-coated gold nanorods produced by green synthesis with activity against Candida albicans. Virulence. 2024;15(1):2416550. doi:10.1080/21505594.2024.2416550.

Balwierz R, Biernat P, Bursy D, Shanaida M, Kasperkiewicz K, Jasińska-Balwierz A, Ochędzan-Siodłak W. Effect of adding gold nanoparticles on the anti-candidal activity and release profile of itraconazole from hydrogels. Appl Sci (Basel). 2024;14(23):11125. doi:10.3390/app142311125.

Mariano-Neto F, Pereira TC. Recent nanoninformatics approaches for developments in nanobiotechnology and nanomedicine [Preprint]. arXiv; 2024. arXiv:2401.10365.

Checker VG, Sharma B, Kathpalia R. Nanoinformatics - a newly introduced tool for research. Indian J Biochem Biophys. 2022;59(4):431-439. doi:10.56042/ijbb.v59i4.61939.

Abughalia A, Flynn M, Clarke PFA, Fayne D, Gobbo OL. The use of computational approaches to design nanodelivery systems. Nanomaterials (Basel). 2025;15(17):1354. doi:10.3390/nano15171354.

Mary P, Mujeeb A. Machine learning ensemble models for predicting the antibacterial efficacy of gold nanoparticles. Mater Res Express. 2025;12(11):115011. doi:10.1088/2053-1591/ae1dce.

Ahmadi M, Ayyoubzadeh SM, Ghorbani-Bidkorpeh F. Toxicity prediction of nanoparticles using machine learning approaches. Toxicology. 2024;501:153697. doi:10.1016/j.tox.2023.153697.

Singh AV, Varma M, Laux P, Choudhary S, Datusalia AK, Gupta N, et al. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review. Arch Toxicol. 2023;97:963-979. doi:10.1007/s00204-023-03471-x.

Han H, Shaker B, Lee JH, Choi S, Yoon S, Singh M, et al. Employing automated machine learning (AutoML) methods to facilitate the in silico ADMET properties prediction. J Chem Inf Model. 2025;65(7):3215-3225. doi:10.1021/acs.jcim.4c02122.

Downloads

Published

2026-03-27

How to Cite

1.
Farwa Butt, Afriaz Khan, Bahaaeldin Anwer, Saliha Khalid. Bioinformatics-Driven Molecular Docking and Molecular Dynamics Simulation of Gold Nanoparticle Ligand Complexes for Targeted Antimicrobial Applications. IJHR [Internet]. 2026 Mar. 27 [cited 2026 Aug. 19];4(3):1-11. Available from: https://insightsjhr.com/index.php/home/article/view/1734